EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The State of the Art of Pediatric Multiple Sclerosis

Raluca Ioana Teleanu, Adelina-Gabriela Niculescu iD, Oana Aurelia Vladacenco, Eugenia Roza iD, Radu-Stefan Perjoc iD, Daniel Mihai Teleanu

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098251 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Raluca Ioana Teleanu und 5 weiteren Autor:innen. Beteiligte Einrichtung: "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Publish not Perish 2023 programme, “Carol Davila” University of Medicine and Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) represents a chronic immune-mediated neurodegenerative disease of the central nervous system that generally debuts around the age of 20–30 years. Still, in recent years, MS has been increasingly recognized among the pediatric population, being characterized by several peculiar features compared to adult-onset disease. Unfortunately, the etiology and disease mechanisms are poorly understood, rendering the already limited MS treatment options with uncertain efficacy and safety in pediatric patients. Thus, this review aims to shed some light on the progress in MS therapeutic strategies specifically addressed to children and adolescents. In this regard, the present paper briefly discusses the etiology, risk factors, comorbidities, and diagnosis possibilities for pediatric-onset MS (POMS), further moving to a detailed presentation of current treatment strategies, recent clinical trials, and emerging alternatives. Particularly, promising care solutions are indicated, including new treatment formulations, stem cell therapies, and cognitive training methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisNeurodegenerative DiseasesAdolescentAdultHumansChildYoung AdultCentral Nervous SystemRisk FactorsDiagnosis, Differential

Stichwörter der Autor:innen

clinical trialsemerging therapeutic strategiesmultiple sclerosis treatmentpediatric multiple sclerosis

Autor:innen und Institutionen

  • "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Department of Pediatric Neurology, "Dr. Victor Gomoiu" Children's Hospital, 022102 Bucharest, Romania.
  • Research Institute of the University of Bucharest-ICUB, University of Bucharest, 050657 Bucharest, Romania.
  • Department of Science and Engineering of Oxide Materials and Nanomaterials, Politehnica University of Bucharest, 011061 Bucharest, Romania.
  • Department of Neurosurgery, Emergency University Hospital, 050098 Bucharest, Romania.

ORCID-Profile: Adelina-Gabriela Niculescu, Eugenia Roza, Radu-Stefan Perjoc

Förderung

  • Publish not Perish 2023 programme, “Carol Davila” University of Medicine and Pharmacy

Zitieren

APA

Teleanu, R. I., Niculescu, A. G., Vladacenco, O. A., Roza, E., Perjoc, R. S., & Teleanu, D. M. (2023). The State of the Art of Pediatric Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098251

Vancouver

Teleanu RI, Niculescu AG, Vladacenco OA, Roza E, Perjoc RS, Teleanu DM. The State of the Art of Pediatric Multiple Sclerosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098251

BibTeX
@article{Teleanu2023,
  author = {Teleanu, Raluca Ioana and Niculescu, Adelina-Gabriela and Vladacenco, Oana Aurelia and Roza, Eugenia and Perjoc, Radu-Stefan and Teleanu, Daniel Mihai},
  title = {The State of the Art of Pediatric Multiple Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098251}
}
Kostenlos starten →